PDB Short entry for 4OAR HEADER TRANSCRIPTION/PEPTIDE 06-JAN-14 4OAR TITLE PROGESTERONE RECEPTOR WITH BOUND ULIPRISTAL ACETATE AND A PEPTIDE FROM TITLE 2 THE CO-REPRESSOR SMRT COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: STEROID-BINDING REGION; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDE FROM NUCLEAR RECEPTOR COREPRESSOR 2; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 2346-2362; COMPND 11 SYNONYM: SMRT PEPTIDE; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR3C3, PGR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 CODON PLUS (DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_CELLULAR_LOCATION: CYTOPLASM; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_VECTOR: PGEXKG; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PGEXHPRLBD; SOURCE 13 MOL_ID: 2; SOURCE 14 SYNTHETIC: YES; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606 KEYWDS PROGESTERONE RECEPTOR, STEROID RECEPTOR, NUCLEAR RECEPTOR, KEYWDS 2 TRANSCRIPTION FACTOR, WOMEN HEALTH, CONTRACEPTION, TRANSCRIPTION- KEYWDS 3 PEPTIDE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.PETIT-TOPIN,M.R.FAY,M.RESCHE-RIGON,A.ULMANN,E.GAINER,M.-E.RAFESTIN- AUTHOR 2 OBLIN,J.FAGART REVDAT 2 20-SEP-23 4OAR 1 COMPND REMARK SEQADV HETNAM REVDAT 1 08-OCT-14 4OAR 0 JRNL AUTH I.PETIT-TOPIN,M.FAY,M.RESCHE-RIGON,A.ULMANN,E.GAINER, JRNL AUTH 2 M.E.RAFESTIN-OBLIN,J.FAGART JRNL TITL MOLECULAR DETERMINANTS OF THE RECOGNITION OF ULIPRISTAL JRNL TITL 2 ACETATE BY OXO-STEROID RECEPTORS. JRNL REF J.STEROID BIOCHEM.MOL.BIOL. V.44PB 427 2014 JRNL REFN ISSN 0960-0760 JRNL PMID 25204619 JRNL DOI 10.1016/J.JSBMB.2014.08.008 REMARK 2 REMARK 2 RESOLUTION. 2.41 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.41 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.59 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2465515.740 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.8 REMARK 3 NUMBER OF REFLECTIONS : 13598 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 680 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.41 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2791 REMARK 3 BIN FREE R VALUE : 0.3015 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 67 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2039 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.36000 REMARK 3 B22 (A**2) : 0.36000 REMARK 3 B33 (A**2) : -0.73000 REMARK 3 B12 (A**2) : -0.41000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.30 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 2.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.080 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.110 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.920 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.670 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.520 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 42.95 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OAR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084256. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 78 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87260 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13598 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 43.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.8 REMARK 200 DATA REDUNDANCY : 6.650 REMARK 200 R MERGE (I) : 0.08900 REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.41 REMARK 200 R MERGE FOR SHELL (I) : 0.39900 REMARK 200 R SYM FOR SHELL (I) : 0.32500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2OVH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG3350, TRIS,HCL 50MM, NACL REMARK 280 400MM, 10% GLYCEROL, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.60667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.30333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.30333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 60.60667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 676 REMARK 465 SER A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 ALA A 900 REMARK 465 LEU A 901 REMARK 465 SER A 902 REMARK 465 VAL A 903 REMARK 465 GLU A 904 REMARK 465 PHE A 905 REMARK 465 PRO A 906 REMARK 465 GLU A 907 REMARK 465 MET A 908 REMARK 465 LYS A 932 REMARK 465 LYS A 933 REMARK 465 THR B 2346 REMARK 465 ASN B 2347 REMARK 465 MET B 2348 REMARK 465 GLY B 2360 REMARK 465 LYS B 2361 REMARK 465 TYR B 2362 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLN A 886 OE1 GLN A 886 4555 1.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 782 80.54 -153.80 REMARK 500 PHE A 794 45.25 -150.59 REMARK 500 SER A 837 52.48 -102.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2S0 A 1001 DBREF 4OAR A 678 933 UNP P06401 PRGR_HUMAN 678 933 DBREF 4OAR B 2346 2362 UNP Q9Y618 NCOR2_HUMAN 2346 2362 SEQADV 4OAR GLY A 676 UNP P06401 EXPRESSION TAG SEQADV 4OAR SER A 677 UNP P06401 EXPRESSION TAG SEQRES 1 A 258 GLY SER GLY GLN ASP ILE GLN LEU ILE PRO PRO LEU ILE SEQRES 2 A 258 ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE TYR ALA SEQRES 3 A 258 GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SER LEU SEQRES 4 A 258 LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN LEU LEU SEQRES 5 A 258 SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY PHE ARG SEQRES 6 A 258 ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE GLN TYR SEQRES 7 A 258 SER TRP MET SER LEU MET VAL PHE GLY LEU GLY TRP ARG SEQRES 8 A 258 SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR PHE ALA SEQRES 9 A 258 PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS GLU SER SEQRES 10 A 258 SER PHE TYR SER LEU CYS LEU THR MET TRP GLN ILE PRO SEQRES 11 A 258 GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU GLU PHE SEQRES 12 A 258 LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR ILE PRO SEQRES 13 A 258 LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU GLU MET SEQRES 14 A 258 ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA ILE GLY SEQRES 15 A 258 LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN ARG PHE SEQRES 16 A 258 TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS ASP LEU SEQRES 17 A 258 VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR PHE ILE SEQRES 18 A 258 GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU MET MET SEQRES 19 A 258 SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE LEU ALA SEQRES 20 A 258 GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 B 17 THR ASN MET GLY LEU GLU ALA ILE ILE ARG LYS ALA LEU SEQRES 2 B 17 MET GLY LYS TYR HET 2S0 A1001 35 HETNAM 2S0 [(8S,11R,13S,14S,17R)-17-ACETYL-11-[4-(DIMETHYLAMINO) HETNAM 2 2S0 PHENYL]-13-METHYL-3-OXO-1,2,6,7,8,11,12,14,15,16- HETNAM 3 2S0 DECAHYDROCYCLOPEN TA[A]PHENANTHREN-17-YL] ACETATE HETSYN 2S0 ULIPRISTAL ACETATE FORMUL 3 2S0 C30 H37 N O4 FORMUL 4 HOH *42(H2 O) HELIX 1 1 PRO A 685 ILE A 694 1 10 HELIX 2 2 THR A 710 LYS A 734 1 25 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 TYR A 753 1 11 HELIX 5 5 SER A 754 SER A 772 1 19 HELIX 6 6 ASN A 785 SER A 792 1 8 HELIX 7 7 PHE A 794 TRP A 802 1 9 HELIX 8 8 TRP A 802 GLN A 812 1 11 HELIX 9 9 SER A 814 LEU A 827 1 14 HELIX 10 10 SER A 837 LEU A 858 1 22 HELIX 11 11 GLY A 862 ARG A 899 1 38 HELIX 12 12 SER A 910 LEU A 917 1 8 HELIX 13 13 PRO A 918 ILE A 920 5 3 HELIX 14 14 LEU B 2350 MET B 2359 1 10 SHEET 1 A 2 LEU A 776 ALA A 779 0 SHEET 2 A 2 LEU A 782 LEU A 784 -1 O LEU A 784 N LEU A 776 SHEET 1 B 2 THR A 829 ILE A 830 0 SHEET 2 B 2 LYS A 926 PRO A 927 -1 O LYS A 926 N ILE A 830 SITE 1 AC1 10 LEU A 718 ASN A 719 GLY A 722 GLU A 723 SITE 2 AC1 10 GLN A 725 ARG A 766 LEU A 797 CYS A 891 SITE 3 AC1 10 THR A 894 HOH A1129 CRYST1 87.180 87.180 90.910 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011471 0.006623 0.000000 0.00000 SCALE2 0.000000 0.013245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011000 0.00000